EU regulators move up Pfizer vaccine assessment to December 21

The European Union’s medicines agency says it has moved up a meeting to assess the Pfizer-BioNTech coronavirus vaccine for provisional approval in the 27-nation bloc to December 21.

The agency says it made the decision after receiving additional data from the vaccine makers.

The announcement comes after Germany’s health minister and others publicly demanded that the agency move quicker than its previously planned December 29 meeting at which it was to discuss approving the vaccine.

The vaccine is already being given to thousands of people in Britain, Canada and the United States.

— AP

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.